- Latest available (Revised)
- Original (As made)
There are outstanding changes not yet made by the legislation.gov.uk editorial team to The Cosmetic Products (Safety) Regulations 2008. Any changes that have already been made by the team appear in the content and are referenced with annotations.
Revised legislation carried on this site may not be fully up to date. Changes and effects are recorded by our editorial team in lists which can be found in the ‘Changes to Legislation’ area. Where those effects have yet to be applied to the text of the legislation by the editorial team they are also listed alongside the legislation in the affected provisions. Use the ‘more’ link to open the changes and effects relevant to the provision you are viewing.
Whole provisions yet to be inserted into this Instrument (including any effects on those provisions):
For the purposes of this Regulation, UV filters are substances which, contained in cosmetic sun-screen products, are specifically intended to filter certain UV rays in order to protect the skin from certain harmful effects of these rays.
The UV filters may be added to other cosmetic products within the limits and under the conditions laid down in this Schedule.
Other UV filters used in cosmetic products solely for the purpose of protecting the product against UV rays are not included in this list.
1 Not required if concentration is 0.5% or less and when it is used only for product protection purposes. | ||||
Reference No | Substances | Maximum authorised concentration | Other limitations and requirements | Conditions of use and warnings which must be printed on the label |
---|---|---|---|---|
a | b | c | d | e |
1 | F1. . . | F1. . . | ||
2 | N,N,N-Trimethyl-4-(2-oxoborn-3-ylidenemethyl) anilinium methyl sulphate | 6.0% | ||
3 | Homosalate (INN) | 10% | ||
4 | Oxybenzone (INN) | 10% | Contains oxybenzone1 | |
5 | [omitted] | |||
6 | 2-phenylbenzimidazole-5-sulfonic acid and its potassium, sodium and triethanolamine salts | 8% (expressed as acid) | ||
7 | 3,3'-(1,4-Phenylenedimethylene) bis (7, 7-dimethyl-2-oxobicyclo-[2,2,1]hept-1-ylmethanesulfonic acid) and its salts | 10% (expressed as acid) | ||
8 | 1-(4-tert-butylphenyl)-3-(4-methoxyphenyl) propane-1,3-dione | 5% | ||
9 | alpha-(2-Oxoborn-3-ylidene)-toluene-4-sulfonic acid and its salts | 6% (expressed as acid) | ||
10 | 2-cyano-3,3-diphenyl acrylic acid, 2-ethylhexyl ester (Octocrylene) | 10% (expressed as acid) | ||
11 | Polymer of N-{(2 and 4)-[(2-oxoborn-3-ylidene)methyl]-benzyl}acrylamide | 6% | ||
12 | Octyl methoxycinnamate | 10% | ||
13 | Ethoxylated Ethyl-4-Aminobenzoate (PEG-25 PABA) | 10% | ||
14 | Isopentyl-4-methoxycinnamate (Isoamyl p-Methoxycinnamate) | 10% | ||
15 | 2,4,6-Trianilino-(p-Carbo-2'-Ethylhexyl-1'Oxy)-1,3,5-Triazine (Octyl Triazone) | 5% | ||
16 | Phenol,2-(2H-Benzotriazol-2-yl)-4-Methyl-6-(2-Methyl-3-(1,3,3,3-Tetramethyl-I-(Trimethylsilyl)Oxy)-Disiloxanyl)Propyl) (Drometrizole Trisiloxane) | 15% | ||
17 | Benzoic acid, 4,4-((6-(((1,1-dimethylethyl)amino)car-bonyl)phenyl)amino)1,3,5-triazine-2,4-diyl)diimino)bis-, bis-(2-ethylhexyl)ester) | 10% | ||
18 | 3-(4'-Methylbenxylidene)-d-1 camphor(4-Methylbenzylidene Camphor) | 4% | ||
19 | 3-Benzylidene camphor (3-Benzylidene Camphor) | 2% | ||
20 | 2-Ethylhexyl salicylate (Octyl-salicylate) | 5% | ||
21 | 4-Dimethyl-amino-benzoate of ethyl-2-hexyl (octyl dimethyl PABA) | 8% | ||
22 | 2-Hydroxy-4-methoxybenzophenone-5-sulfonic acid (Benzophenone-5) and its sodium salt | 5% (expressed as acid) | ||
23 | 2,2'-Methylene-bis-6-(2H-benzotriazol-2yl)-4-(tetramethyl-butyl)-1,1,3,3-phenol | 10% | ||
24 | Monosodium salt of 2-2'-bis-(1,4-phenylene) 1H-benzimidazole-4,6-disulphonic acid) | 10% (expressed as acid) | ||
25 | (1,3,5)-Triazine-2,4-bis((4-(2-ethyl-hexyloxy)-2-hydroxy)-phenyl)-6-(4-methoxyphenyl) | 10% | ||
26 | Dimethicodiethylbenzal-malonate (CAS No 207574-74-1) | 10% | ||
27 | Titanium dioxide | 25% | ||
28 | Benzoic acid, 2-[-4-(diethylamino)-2-hydroxybenzoyl]-, hexylester (INCI name: Diethylamino Hydroxybenzoyl Hexyl Benzoate; CAS No 302776-68-7) | 10% F2... |
Textual Amendments
F1Words in Sch. 7 Pt. 1 repealed (8.10.2009) by The Cosmetic Products (Safety) (Amendment No.2) Regulations 2009 (S.I. 2009/1346), regs. 1(3), 2(d)(i)
F2Words in Sch. 7 Pt. 1 repealed (8.7.2009) by The Cosmetic Products (Safety) (Amendment No.2) Regulations 2009 (S.I. 2009/1346), regs. 1(2), 2(d)(ii)
The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
The Schedules you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: